Cypress Wealth Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Cypress Wealth Services's PFE Position: Q3 2026 in Review
Cypress Wealth Services reduced its Pfizer (PFE) stake by 2.8% in Q3 2026, selling an estimated $14K and leaving 18,546 shares worth $510K. The position accounts for 0.06% of the portfolio, ranked #235.
Cypress Wealth Services first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.28M in Q4 2020. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Cypress Wealth Services held 18,546 shares of Pfizer worth $510K as of Q3 2026.
- Cypress Wealth Services sold 528 Pfizer shares in Q3 2026, an estimated $14K.
- Pfizer made up 0.06% of Cypress Wealth Services's portfolio in Q3 2026, its #235 holding.
- Cypress Wealth Services first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Cypress Wealth Services's Pfizer position peaked at $1.28M in Q4 2020.
- 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.